Similar Articles
Correlation between clinical disease activity and sacroiliac magnetic resonance imaging detection in axial spondyloarthropathy
Ozenc Inan, Ebru Aytekin, Yasemin Pekin Dogan, Ilhan Nahit Mutlu, Kübra Aydemir, Nuran Oz, Nil Sayiner Caglar
DOI: 10.46497/ArchRheumatol.2024.10401
Early effectiveness and safety analysis of belimumab in addition to standard treatment in patients with systemic lupus erythematosus
Lingyan He, Mingming Yan, Rui Wen, Jiali Li
DOI: 10.46497/ArchRheumatol.2024.9977
Biological treatment in elderly and young patients with ankylosing spondylitis: TURKBIO real-life data results
Sadettin Uslu, Semih Gülle, Özkan Urak, Gerçek Şen, Ediz Dalkılıç, Soner Şenel, Servet Akar, Nevsun İnanç, Ayşe Cefle, Aydan Köken Avşar, Servet Yolbaş, Sema Yılmaz, Özgül Soysal Gündüz, İsmail Sarı, Merih Birlik, Nurullah Akkoç, Fatoş Önen
DOI: 10.46497/ArchRheumatol.2024.10391
Deficiency of interleukin-1 receptor antagonist: A systematic review
Wérgila Ruana Gonçalves Barros, Jucier Gonçalves Júnior
DOI: 10.46497/ArchRheumatol.2024.10882
Increased PCSK9 associated with cIMT in AS: A useful marker for subclinical atherosclerosis in patients with ankylosing spondylitis
Ahmet Karakoyun, Yasemin Akkubak, Mevlüt Hakan Göktepe, Pınar Diydem Yılmaz, Cengiz Kadıyoran, Mustafa Oğul, Adem Kucuk
DOI: 10.46497/ArchRheumatol.2024.10625